Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

More On GTG.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Genetic Technologies Limited (GTG.AX)

-ASX
0.03 Down 0.00(3.03%) Jul 31
Prev Close:0.03
Open:0.03
Bid:0.03
Ask:0.03
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.03 - 0.03
52wk Range:0.03 - 0.11
Volume:180,404
Avg Vol (3m):233,811
Market Cap:18.61M
P/E (ttm):N/A
EPS (ttm):-0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.28
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-14) :-0.01
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Genetic Technologies Limited provides genetic testing services primarily in Australia and the United States. It offers a range of DNA based genetic tests for cancer predisposition, including breast cancer, ovarian cancer, bowel cancer, and uterine... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback